MENU
NAMS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
NewAmsterdam Pharma (NAMS) Ownership - Who owns NewAmsterdam Pharma?
Profile
Industry
N/A
Address
Gooimeer 2-35
Phone
+31 352062971
Employees
29
Web
https://www.newamsterdampharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.31B
P/E Ratio
N/A
Total Cash
430.71M
Projected Growth
N/A
Total Debt
562K
Revenue
7.42M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
4.66
Total Debt/Equity
N/A
Revenue/Share
0.37 USD as % of share price
Fundamentals
NAMS
Capitalization
2.31B
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
431M
Total Cash/Share
4.66
Total Debt
562K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.37%
Revenue
7.42M
ROE
N/A
Book Value
387M
P/B Ratio
6.09
Cash Flow
N/A
Earnings
-2.62
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
11.2M
Current Ratio
9.83
Current Revenue Per Employee
39982.46
Dividends Per Share - Security
N/A
EBITDA
-205.21M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-47.86
Shares Held By Institutions
1.26B
Shares Outstanding - Current
92.4M
Total Liabilities
59.3M
Total Volume MTD
N/A
Value
-1
Gain YTD
123.545
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Gooimeer 2-35
Phone
+31 352062971
Employees
29
Web
https://www.newamsterdampharma.com